This company listing is no longer active
McKesson Europe Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for McKesson Europe.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 27.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)
Dec 23
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
Sep 01These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong
May 19McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital
Jan 27Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal
Sep 07McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns
Apr 29What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition
Mar 20Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?
Feb 13
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as McKesson Europe has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2022 | 9,257 | -54 | -27 | 1 | N/A |
| 3/31/2021 | 8,518 | 3 | 307 | 363 | N/A |
| 3/31/2020 | 17,118 | -71 | 184 | 313 | N/A |
| 3/31/2019 | 16,417 | -47 | 208 | 345 | N/A |
| 3/31/2018 | 21,090 | -303 | 138 | 266 | N/A |
| 3/31/2017 | 20,644 | -807 | 267 | 422 | N/A |
| 12/31/2016 | 20,475 | -76 | N/A | N/A | N/A |
| 9/30/2016 | 21,118 | 437 | 127 | 284 | N/A |
| 6/30/2016 | 21,265 | 459 | 217 | 385 | N/A |
| 3/31/2016 | 21,193 | 487 | 139 | 301 | N/A |
| 3/31/2015 | 21,076 | 129 | N/A | -284 | N/A |
| 12/31/2014 | 20,647 | 187 | N/A | 233 | N/A |
| 9/30/2014 | 21,877 | 79 | N/A | 211 | N/A |
| 6/30/2014 | 21,606 | 64 | N/A | 206 | N/A |
| 3/31/2014 | 21,426 | 167 | N/A | 367 | N/A |
| 12/31/2013 | 21,408 | 165 | N/A | 412 | N/A |
| 9/30/2013 | 21,565 | 146 | N/A | 396 | N/A |
| 6/30/2013 | 21,753 | 153 | N/A | 274 | N/A |
| 3/31/2013 | 21,990 | 99 | N/A | 304 | N/A |
| 12/31/2012 | 22,271 | 103 | N/A | 422 | N/A |
| 9/30/2012 | 22,339 | 51 | N/A | 401 | N/A |
| 6/30/2012 | 22,347 | 72 | N/A | 616 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CLS1's forecast earnings growth is above the savings rate (0.2%).
Earnings vs Market: Insufficient data to determine if CLS1's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if CLS1's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CLS1's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if CLS1's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CLS1's Return on Equity is forecast to be high in 3 years time